» Authors » Michaela Diamant

Michaela Diamant

Explore the profile of Michaela Diamant including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 213
Citations 9022
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
van Duinkerken E, IJzerman R, Barkhof F, Moll A, Diamant M, Snoek F, et al.
Diabetes Care . 2021 Aug; PMID: 34380705
Objective: While the apolipoprotein E 4 allele (ApoE-4) is related to cognitive and brain decline in the general population, its effect on the brain in type 1 diabetes mellitus (T1DM)...
2.
van Duinkerken E, Bernardes G, van Bloemendaal L, Veltman D, Barkhof F, Mograbi D, et al.
Diabetes Obes Metab . 2020 Oct; 23(2):415-424. PMID: 33084088
Aim: To assess the effects of Roux-en-Y gastric bypass surgery (RYGB)-related changes in glucagon-like peptide-1 (GLP-1) on cerebral resting-state functioning in obese women. Materials And Methods: In nine obese females...
3.
Verwer B, Scheffer P, Vermue R, Pouwels P, Diamant M, Tushuizen M
Liver Int . 2020 Jul; 40(10):2439-2444. PMID: 32652824
NAFLD is closely related with the metabolic syndrome (MetS) and increased risk of cardiovascular disease. Liver fat associates with post-prandial hypertriglyceridemia, potentially contributing to triglyceride-enrichment of high-density lipoproteins (HDL-TG), and...
4.
Emanuel A, Meijer R, Woerdeman J, van Raalte D, Diamant M, Kramer M, et al.
Arterioscler Thromb Vasc Biol . 2020 May; 40(7):1695-1704. PMID: 32404008
Objective: In mice fed a high-fat diet, impairment of insulin signaling in endothelium is an early phenomenon that precedes decreased insulin sensitivity of skeletal muscle, adipose tissue, and liver. We...
5.
6.
Emanuel A, van Duinkerken E, Wattjes M, Klein M, Barkhof F, Snoek F, et al.
Microcirculation . 2019 Jan; 26(3):e12530. PMID: 30659710
Objective: Cognitive impairments in type 1 diabetes may result from hyperglycemia-associated cerebral microangiopathy. We aimed to identify cerebral microangiopathy and skin microvascular dysfunction-as a surrogate marker for generalized microvascular function-as...
7.
Tonneijck L, Muskiet M, Blijdorp C, Smits M, Twisk J, Kramer M, et al.
Am J Physiol Renal Physiol . 2018 Oct; 316(2):F231-F240. PMID: 30353743
Glucagon-like peptide-1 (GLP-1) receptor agonists (RAs) are well-established glucose-lowering drugs for type 2 diabetes mellitus (T2DM) management. Acute GLP-1RA administration increases urinary excretion of sodium and other electrolytes. However, the...
8.
van Duinkerken E, Steenwijk M, Klein M, Barkhof F, Mograbi D, Diamant M, et al.
J Diabetes . 2018 Apr; 10(11):835-846. PMID: 29665283
Background: The aim of the present study was to determine trajectories of cognitive and cortical changes over time in middle-aged patients with type 1 diabetes mellitus (T1DM) and proliferative retinopathy....
9.
Bernardes G, IJzerman R, Ten Kulve J, Barkhof F, Diamant M, Veltman D, et al.
Metab Brain Dis . 2018 Apr; 33(4):1211-1222. PMID: 29654499
Type 2 diabetes (T2DM) is associated with structural cortical and subcortical alterations, although it is insufficiently clear if these alterations are driven by obesity or by diabetes and its associated...
10.
Tonneijck L, Muskiet M, Smits M, Bjornstad P, Kramer M, Diamant M, et al.
Diabetes Obes Metab . 2018 Jan; 20(5):1235-1245. PMID: 29341461
Aims: To determine the effects of glucagon-like peptide (GLP)-1 receptor agonists (RA) on uric acid (UA) levels and kidney UA clearance. Material And Methods: This study involved post-hoc analyses of...